Ubiquitin-Specific Protease 43 Impacts Pancreatic Ductal Adenocarcinoma Prognosis by Altering Its Proliferation and Infiltration of Surrounding Immune Cells

Background. Pancreatic ductal adenocarcinoma (PDAC) is a devastating cancer, and the therapy options for PDAC remain restricted. The distinctive tumor immunological microenvironment (TIME) of PDAC, comprising a high number of stromal cells and a limited infiltration of cytotoxic T lymphocytes (CTLs)...

Full description

Bibliographic Details
Main Authors: Ziqi Zhao, Zhikun Lin, Xin Guo, Abdullah Al-danakh, Hui He, Henan Qin, Chi Ma, Ningning Zhang, Guang Tan
Format: Article
Language:English
Published: Hindawi Limited 2023-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2023/4311388
_version_ 1797849746579128320
author Ziqi Zhao
Zhikun Lin
Xin Guo
Abdullah Al-danakh
Hui He
Henan Qin
Chi Ma
Ningning Zhang
Guang Tan
author_facet Ziqi Zhao
Zhikun Lin
Xin Guo
Abdullah Al-danakh
Hui He
Henan Qin
Chi Ma
Ningning Zhang
Guang Tan
author_sort Ziqi Zhao
collection DOAJ
description Background. Pancreatic ductal adenocarcinoma (PDAC) is a devastating cancer, and the therapy options for PDAC remain restricted. The distinctive tumor immunological microenvironment (TIME) of PDAC, comprising a high number of stromal cells and a limited infiltration of cytotoxic T lymphocytes (CTLs), rendered immunotherapy ineffective. The protein level of ubiquitin-specific protease 43 (USP43) was a prognostic predictor in numerous cancers; however, its function in PDAC is limited. This article focuses on the influence of USP43 expression on PDAC prognosis and TIME alteration. Methods. Based on TCGA database and tissue microarray staining, the expression of USP43 in PDAC was evaluated. The association between USP43 and prognosis was then investigated using tissue samples and online databases. In PDAC tumor tissues, the correlation between USP43 expression and clinicopathological characteristics, immune cell infiltration, and prognosis was investigated. The expression of USP43 in PDAC cell lines was evaluated using quantitative polymerase chain reaction. Using a cell counting kit-8 (CCK-8) and a cell colony formation test, the viability of the cells was determined. On the basis of online databases and tissue samples, the link between USP43 and immune cell infiltration around PDAC was also examined. For statistical analyses, the software GraphPad, R, and SPSS 26.0 were utilized. Results. The expression of USP43 was considerably higher in PDAC compared to normal pancreatic tissue in both the TCGA database and the tissue microarrays of PDAC patients (P<0.001). High USP43 expression was associated with poor overall survival in both the TCGA database and the tissue microarray of PDAC patients (P=0.046 and 0.021, respectively). USP43 overexpression promoted PANC-1 cell proliferation (P=0.0018), but USP43 knockdown decreased PANC02 cell proliferation (P<0.001). According to the TCGA database, USP43 is associated with T cell activation and inhibits CD8+ T cell activation in PDAC, as proven by a study of cell lines. Moreover, in both TCGA and PDAC cell lines, USP43 expression was negatively linked with the chemokine signaling pathway. Conclusions. Overexpression of USP43 is a potential prognostic indicator for PDAC patients. USP43 is a potential biomarker associated with T cell activation, suppression of CD8+ T cell enrichment, and the cytokine signal pathway. Future multicenter studies are needed to confirm our findings and their potential application in the treatment of PDAC patients.
first_indexed 2024-04-09T18:49:05Z
format Article
id doaj.art-105c28dd76784414a30d97d4c953b9d1
institution Directory Open Access Journal
issn 2314-7156
language English
last_indexed 2024-04-09T18:49:05Z
publishDate 2023-01-01
publisher Hindawi Limited
record_format Article
series Journal of Immunology Research
spelling doaj.art-105c28dd76784414a30d97d4c953b9d12023-04-10T00:13:59ZengHindawi LimitedJournal of Immunology Research2314-71562023-01-01202310.1155/2023/4311388Ubiquitin-Specific Protease 43 Impacts Pancreatic Ductal Adenocarcinoma Prognosis by Altering Its Proliferation and Infiltration of Surrounding Immune CellsZiqi Zhao0Zhikun Lin1Xin Guo2Abdullah Al-danakh3Hui He4Henan Qin5Chi Ma6Ningning Zhang7Guang Tan8Department of General SurgeryDepartment of General SurgeryDepartment of General SurgeryDepartment of UrologyDepartment of General SurgeryDepartment of OncologyDepartment of General SurgeryDepartment of HematologyDepartment of General SurgeryBackground. Pancreatic ductal adenocarcinoma (PDAC) is a devastating cancer, and the therapy options for PDAC remain restricted. The distinctive tumor immunological microenvironment (TIME) of PDAC, comprising a high number of stromal cells and a limited infiltration of cytotoxic T lymphocytes (CTLs), rendered immunotherapy ineffective. The protein level of ubiquitin-specific protease 43 (USP43) was a prognostic predictor in numerous cancers; however, its function in PDAC is limited. This article focuses on the influence of USP43 expression on PDAC prognosis and TIME alteration. Methods. Based on TCGA database and tissue microarray staining, the expression of USP43 in PDAC was evaluated. The association between USP43 and prognosis was then investigated using tissue samples and online databases. In PDAC tumor tissues, the correlation between USP43 expression and clinicopathological characteristics, immune cell infiltration, and prognosis was investigated. The expression of USP43 in PDAC cell lines was evaluated using quantitative polymerase chain reaction. Using a cell counting kit-8 (CCK-8) and a cell colony formation test, the viability of the cells was determined. On the basis of online databases and tissue samples, the link between USP43 and immune cell infiltration around PDAC was also examined. For statistical analyses, the software GraphPad, R, and SPSS 26.0 were utilized. Results. The expression of USP43 was considerably higher in PDAC compared to normal pancreatic tissue in both the TCGA database and the tissue microarrays of PDAC patients (P<0.001). High USP43 expression was associated with poor overall survival in both the TCGA database and the tissue microarray of PDAC patients (P=0.046 and 0.021, respectively). USP43 overexpression promoted PANC-1 cell proliferation (P=0.0018), but USP43 knockdown decreased PANC02 cell proliferation (P<0.001). According to the TCGA database, USP43 is associated with T cell activation and inhibits CD8+ T cell activation in PDAC, as proven by a study of cell lines. Moreover, in both TCGA and PDAC cell lines, USP43 expression was negatively linked with the chemokine signaling pathway. Conclusions. Overexpression of USP43 is a potential prognostic indicator for PDAC patients. USP43 is a potential biomarker associated with T cell activation, suppression of CD8+ T cell enrichment, and the cytokine signal pathway. Future multicenter studies are needed to confirm our findings and their potential application in the treatment of PDAC patients.http://dx.doi.org/10.1155/2023/4311388
spellingShingle Ziqi Zhao
Zhikun Lin
Xin Guo
Abdullah Al-danakh
Hui He
Henan Qin
Chi Ma
Ningning Zhang
Guang Tan
Ubiquitin-Specific Protease 43 Impacts Pancreatic Ductal Adenocarcinoma Prognosis by Altering Its Proliferation and Infiltration of Surrounding Immune Cells
Journal of Immunology Research
title Ubiquitin-Specific Protease 43 Impacts Pancreatic Ductal Adenocarcinoma Prognosis by Altering Its Proliferation and Infiltration of Surrounding Immune Cells
title_full Ubiquitin-Specific Protease 43 Impacts Pancreatic Ductal Adenocarcinoma Prognosis by Altering Its Proliferation and Infiltration of Surrounding Immune Cells
title_fullStr Ubiquitin-Specific Protease 43 Impacts Pancreatic Ductal Adenocarcinoma Prognosis by Altering Its Proliferation and Infiltration of Surrounding Immune Cells
title_full_unstemmed Ubiquitin-Specific Protease 43 Impacts Pancreatic Ductal Adenocarcinoma Prognosis by Altering Its Proliferation and Infiltration of Surrounding Immune Cells
title_short Ubiquitin-Specific Protease 43 Impacts Pancreatic Ductal Adenocarcinoma Prognosis by Altering Its Proliferation and Infiltration of Surrounding Immune Cells
title_sort ubiquitin specific protease 43 impacts pancreatic ductal adenocarcinoma prognosis by altering its proliferation and infiltration of surrounding immune cells
url http://dx.doi.org/10.1155/2023/4311388
work_keys_str_mv AT ziqizhao ubiquitinspecificprotease43impactspancreaticductaladenocarcinomaprognosisbyalteringitsproliferationandinfiltrationofsurroundingimmunecells
AT zhikunlin ubiquitinspecificprotease43impactspancreaticductaladenocarcinomaprognosisbyalteringitsproliferationandinfiltrationofsurroundingimmunecells
AT xinguo ubiquitinspecificprotease43impactspancreaticductaladenocarcinomaprognosisbyalteringitsproliferationandinfiltrationofsurroundingimmunecells
AT abdullahaldanakh ubiquitinspecificprotease43impactspancreaticductaladenocarcinomaprognosisbyalteringitsproliferationandinfiltrationofsurroundingimmunecells
AT huihe ubiquitinspecificprotease43impactspancreaticductaladenocarcinomaprognosisbyalteringitsproliferationandinfiltrationofsurroundingimmunecells
AT henanqin ubiquitinspecificprotease43impactspancreaticductaladenocarcinomaprognosisbyalteringitsproliferationandinfiltrationofsurroundingimmunecells
AT chima ubiquitinspecificprotease43impactspancreaticductaladenocarcinomaprognosisbyalteringitsproliferationandinfiltrationofsurroundingimmunecells
AT ningningzhang ubiquitinspecificprotease43impactspancreaticductaladenocarcinomaprognosisbyalteringitsproliferationandinfiltrationofsurroundingimmunecells
AT guangtan ubiquitinspecificprotease43impactspancreaticductaladenocarcinomaprognosisbyalteringitsproliferationandinfiltrationofsurroundingimmunecells